Issue Date | Title | Author(s) |
2006-10-10 | Acid-cleavable polymeric core-shell particles for delivery of hydrophobic drugs | Chan, Y; Bulmus, V; Zareie, MH; Byrne, FL; Barner, L; Kavallaris, M |
2014-12-01 | Computational analysis of image-based drug profiling predicts synergistic drug combinations: Applications in triple-negative breast cancer | Brandl, MB; Pasquier, E; Li, F; Beck, D; Zhang, S; Zhao, H; Kavallaris, M; Wong, STC |
2023-05-17 | Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. | Moles, E; Howard, CB; Huda, P; Karsa, M; McCalmont, H; Kimpton, K; Duly, A; Chen, Y; Huang, Y; Tursky, ML; Ma, D; Bustamante, S; Pickford, R; Connerty, P; Omari, S; Jolly, CJ; Joshi, S; Shen, S; Pimanda, JE; Dolnikov, A; Cheung, LC; Kotecha, RS; Norris, MD; Haber, M; de Bock, CE; Somers, K; Lock, RB; Thurecht, KJ; Kavallaris, M |
2021-01-13 | Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine | Yeola, A; Subramanian, S; Oliver, RA; Lucas, CA; Thoms, JAI; Yan, F; Olivier, J; Chacon, D; Tursky, ML; Srivastava, P; Potas, JR; Hung, T; Power, C; Hardy, P; D., D; Kilian, KA; McCarroll, J; Kavallaris, M; Hesson, LB; Beck, D; Curtis, DJ; Wong, JWH; Hardeman, EC; Walsh, WR; Mobbs, R; Chandrakanthan, V; Pimanda, JE |
2020-08 | Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia. | Salik, B; Yi, H; Hassan, N; Santiappillai, N; Vick, B; Connerty, P; Duly, A; Trahair, T; Woo, AJ; Beck, D; Liu, T; Spiekermann, K; Jeremias, I; Wang, J; Kavallaris, M; Haber, M; Norris, MD; Liebermann, DA; D'Andrea, RJ; Murriel, C; Wang, JY |